Stoke Therapeutics Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

9.65

-0.22 (-2.23%)

At close: May 02, 2025, 3:59 PM

9.63

-0.21%

After-hours: May 02, 2025, 04:05 PM EDT

Stoke Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-88.98M	-104.7M	-101.07M	-85.81M	-52.24M	-32.33M	-12.52M	-5.56M
Depreciation & Amortization	2.18M	2.47M	1.55M	974K	888K	450K	214K	113K
Stock-Based Compensation	27.47M	25.26M	22.85M	16.45M	5.77M	1.92M	240K	26K
Other Working Capital	-31.23M	-2.82M	42.9M	-2.85M	-2.88M	-2M	1.09M	31K
Other Non-Cash Items	623K	1.94M	1.78M	1.26M	1.04M	3K	10K	4K
Deferred Income Tax	n/a	n/a	n/a	172K	3K	n/a	n/a	n/a
Change in Working Capital	-28.14M	-6.03M	43.02M	46K	2.33M	-1.1M	1.09M	31K
Operating Cash Flow	-86.85M	-81.07M	-31.87M	-66.91M	-42.22M	-31.05M	-10.96M	-5.38M
Capital Expenditures	-203K	-1.62M	-3.96M	-1.2M	-1.05M	-1.64M	-935K	-113K
Cash Acquisitions	n/a	n/a	45.34M	75.23M	n/a	1K	10K	n/a
Purchase of Investments	-167.27M	n/a	-201.32M	-87.23M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	60M	107.56M	159.4M	12M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-45.34M	-75.23M	n/a	1K	10K	n/a
Investing Cash Flow	-107.47M	105.95M	-45.88M	-76.43M	-1.05M	-1.63M	-925K	-113K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.25M	926K	1.06M	1.28M	2.71M	-2.15M	-361K	2.97M
Financial Cash Flow	131.09M	53.01M	46.41M	1.28M	108.11M	149.76M	115.64M	5.97M
Net Cash Flow	-63.23M	77.89M	-31.34M	-142.05M	64.84M	117.07M	103.75M	477K
Free Cash Flow	-87.05M	-82.68M	-35.83M	-68.11M	-43.27M	-32.69M	-11.9M	-5.5M